The global sterilization services market size accounted for USD 5.98 billion in 2025 and is projected to surpass around USD 10.64 billion by 2034, representing a healthy CAGR of 6.63% between 2025 and 2034. The North America sterilization services market size was calculated at USD 2.18 billion in 2024 and is expected to grow at a fastest CAGR of 6.65% during the forecast year. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Sterilization Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Sterilization Services Market, by Method
8.1.1. Gas Modalities
8.1.1.1. Market Revenue and Forecast
8.1.2. Radiation Modalities
8.1.2.1. Market Revenue and Forecast
8.1.3. Dry Heat Sterilization
8.1.3.1. Market Revenue and Forecast
8.1.4. Other Methods
8.1.4.1. Market Revenue and Forecast
9.1. Sterilization Services Market, by Business Type
9.1.1. Contract Sterilization Services
9.1.1.1. Market Revenue and Forecast
9.1.2. Sterilization Validation Services
9.1.2.1. Market Revenue and Forecast
10.1. Sterilization Services Market, by Mode of Delivery
10.1.1. On-Site
10.1.1.1. Market Revenue and Forecast
10.1.2. Off-Site
10.1.2.1. Market Revenue and Forecast
11.1. Sterilization Services Market, by End-Use
11.1.1. Healthcare Facilities
11.1.1.1. Market Revenue and Forecast
11.1.2. Medical Device Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Pharmaceutical And Biotech Companies
11.1.3.1. Market Revenue and Forecast
11.1.4. Other End-Users
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Method
12.1.2. Market Revenue and Forecast, by Business Type
12.1.3. Market Revenue and Forecast, by Mode of Delivery
12.1.4. Market Revenue and Forecast, by End-Use
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Method
12.1.5.2. Market Revenue and Forecast, by Business Type
12.1.5.3. Market Revenue and Forecast, by Mode of Delivery
12.1.5.4. Market Revenue and Forecast, by End-Use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Method
12.1.6.2. Market Revenue and Forecast, by Business Type
12.1.6.3. Market Revenue and Forecast, by Mode of Delivery
12.1.6.4. Market Revenue and Forecast, by End-Use
12.2. Europe
12.2.1. Market Revenue and Forecast, by Method
12.2.2. Market Revenue and Forecast, by Business Type
12.2.3. Market Revenue and Forecast, by Mode of Delivery
12.2.4. Market Revenue and Forecast, by End-Use
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Method
12.2.5.2. Market Revenue and Forecast, by Business Type
12.2.5.3. Market Revenue and Forecast, by Mode of Delivery
12.2.5.4. Market Revenue and Forecast, by End-Use
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Method
12.2.6.2. Market Revenue and Forecast, by Business Type
12.2.6.3. Market Revenue and Forecast, by Mode of Delivery
12.2.6.4. Market Revenue and Forecast, by End-Use
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Method
12.2.7.2. Market Revenue and Forecast, by Business Type
12.2.7.3. Market Revenue and Forecast, by Mode of Delivery
12.2.7.4. Market Revenue and Forecast, by End-Use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Method
12.2.8.2. Market Revenue and Forecast, by Business Type
12.2.8.3. Market Revenue and Forecast, by Mode of Delivery
12.2.8.4. Market Revenue and Forecast, by End-Use
12.3. APAC
12.3.1. Market Revenue and Forecast, by Method
12.3.2. Market Revenue and Forecast, by Business Type
12.3.3. Market Revenue and Forecast, by Mode of Delivery
12.3.4. Market Revenue and Forecast, by End-Use
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Method
12.3.5.2. Market Revenue and Forecast, by Business Type
12.3.5.3. Market Revenue and Forecast, by Mode of Delivery
12.3.5.4. Market Revenue and Forecast, by End-Use
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Method
12.3.6.2. Market Revenue and Forecast, by Business Type
12.3.6.3. Market Revenue and Forecast, by Mode of Delivery
12.3.6.4. Market Revenue and Forecast, by End-Use
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Method
12.3.7.2. Market Revenue and Forecast, by Business Type
12.3.7.3. Market Revenue and Forecast, by Mode of Delivery
12.3.7.4. Market Revenue and Forecast, by End-Use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Method
12.3.8.2. Market Revenue and Forecast, by Business Type
12.3.8.3. Market Revenue and Forecast, by Mode of Delivery
12.3.8.4. Market Revenue and Forecast, by End-Use
12.4. MEA
12.4.1. Market Revenue and Forecast, by Method
12.4.2. Market Revenue and Forecast, by Business Type
12.4.3. Market Revenue and Forecast, by Mode of Delivery
12.4.4. Market Revenue and Forecast, by End-Use
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Method
12.4.5.2. Market Revenue and Forecast, by Business Type
12.4.5.3. Market Revenue and Forecast, by Mode of Delivery
12.4.5.4. Market Revenue and Forecast, by End-Use
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Method
12.4.6.2. Market Revenue and Forecast, by Business Type
12.4.6.3. Market Revenue and Forecast, by Mode of Delivery
12.4.6.4. Market Revenue and Forecast, by End-Use
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Method
12.4.7.2. Market Revenue and Forecast, by Business Type
12.4.7.3. Market Revenue and Forecast, by Mode of Delivery
12.4.7.4. Market Revenue and Forecast, by End-Use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Method
12.4.8.2. Market Revenue and Forecast, by Business Type
12.4.8.3. Market Revenue and Forecast, by Mode of Delivery
12.4.8.4. Market Revenue and Forecast, by End-Use
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Method
12.5.2. Market Revenue and Forecast, by Business Type
12.5.3. Market Revenue and Forecast, by Mode of Delivery
12.5.4. Market Revenue and Forecast, by End-Use
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Method
12.5.5.2. Market Revenue and Forecast, by Business Type
12.5.5.3. Market Revenue and Forecast, by Mode of Delivery
12.5.5.4. Market Revenue and Forecast, by End-Use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Method
12.5.6.2. Market Revenue and Forecast, by Business Type
12.5.6.3. Market Revenue and Forecast, by Mode of Delivery
12.5.6.4. Market Revenue and Forecast, by End-Use
13.1. Steris Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Stryker Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. 3m Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Ecolab Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sterigenics International LLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Cretex Companies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Noxilizer Inc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Beta-Gamma-Service Gmbh & Co. Kg
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cosmed Group Inc.,
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medline Industries Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample